Detalles de la búsqueda
1.
Intranasal vitamin B12 administration in elderly patients: A randomized controlled comparison of two dosage regimens.
Br J Clin Pharmacol
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38747399
2.
Comparison of consistency and complementarity of reporting biosimilar quality attributes between regulatory and scientific communities: An adalimumab case study.
Biologicals
; 69: 30-37, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33454195
3.
Drug-drug interactions with metronidazole and itraconazole in patients using acenocoumarol.
Eur J Clin Pharmacol
; 76(10): 1457-1464, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32524154
4.
Post-marketing dosing changes in the label of biologicals.
Br J Clin Pharmacol
; 85(4): 715-721, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30593087
5.
Biosimilars: what clinicians should know.
Blood
; 120(26): 5111-7, 2012 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23093622
6.
Post-approval quality-related regulatory actions for biopharmaceuticals approved in the European Union and the United States between 1995 and 2019.
Drug Discov Today
; 28(10): 103725, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37487844
7.
Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar.
Therap Adv Gastroenterol
; 16: 17562848231197923, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37706094
8.
Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance.
Expert Opin Biol Ther
; 23(8): 801-817, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36947408
9.
Rituximab-induced thrombocytopenia: a cohort study.
Eur J Haematol
; 89(3): 256-66, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22639923
10.
Nature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products: A 20-year follow-up study of originators and biosimilars.
Eur J Pharm Sci
; 175: 106227, 2022 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636657
11.
Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review.
BioDrugs
; 36(1): 27-39, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34870802
12.
Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars.
Pharmaceuticals (Basel)
; 14(3)2021 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33669108
13.
Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept.
BioDrugs
; 35(6): 765-772, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704199
14.
QTc Prolongation in COVID-19 Patients Using Chloroquine.
Cardiovasc Toxicol
; 21(4): 314-321, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387252
15.
Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions.
Clin Pharmacol Ther
; 110(5): 1311-1317, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34472087
16.
Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF-α Inhibitors.
Clin Pharmacol Ther
; 110(1): 123-131, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33278830
17.
The effect of medication related clinical decision support at the time of physician order entry.
Int J Clin Pharm
; 43(1): 137-143, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32996074
18.
Switching TNFα inhibitors: Patterns and determinants.
Pharmacol Res Perspect
; 9(4): e00843, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34302442
19.
Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review.
Eur J Pharm Sci
; 154: 105501, 2020 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32739253
20.
Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice.
Clin Pharmacol Ther
; 105(4): 962-969, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30460997